Tesamorelin, a manufactured peptide , is gaining increasing notice for its potential advantages within the healthcare field. This novel analogue of growth hormone-releasing hormone (GHRH) functions by stimulating the release of HGH from the brain. While primarily investigated for the management of lipodystrophy – a disorder characterized by abnor